Is TScan Therapeutics TCRX stock worth taking a position in TScan Therapeutics posts narrower loss on 268 EPS beat Barclays iPath Series B SP 500 VIX ShortTerm Futures ETN VXX Volatility Pricing Signals PostGeopolitical Risk Equity Opportunity CTSH Cognizant delivers 3 percent Q1 2026 earnings beat yet shares drop 329 percent amid weak investor sentiment US Federal Reserve Leadership and Policy Independence Update Closure of DOJ Criminal Probe into Jerome Powell US Press Freedom and Public Sector Governance Risk Analysis GAP Gap Inc Q1 2026 EPS narrowly misses analyst estimates sending shares 087 percent lower in todays trade MBAVU M3Brigade lays out SPAC target acquisition priorities and nearterm deal timeline in latest quarterly earnings Avalo AVTX Stock Is It Accelerating Q4 2025 Better Than Expected